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Although T lymphocytes are constitutively nonadher-
ent cells, they undergo facultative polarity during
migration and upon interaction with cells presenting
cognate antigen, suggesting that cell polarity might
be critical for target cell destruction. Using two-pho-
ton imaging of tumor-infiltrating T lymphocytes, we
found that CD44, a receptor for extracellular matrix
proteins and glycosaminoglycans, was crucial for in-
terstitial T cell navigation and, consequently, efficient
tumor cell screening. CD44 functioned as a critical
regulator of intratumoral movement by stabilizing
cell polarity in migrating T cells, but not during target
cell interactions. Stable anterior-posterior asymme-
try was maintained by CD44 independently of its
extracellular domain. Instead, migratory polarity de-
pended on the recruitment of ezrin, radixin, moesin
(ERM) proteins by the intracellular domain of CD44
to the posterior cellular protrusion. Our results for-
mally demonstrate that CD44-dependent T lympho-
cyte locomotion within target sites represents an
essential immunologic checkpoint that determines
the potency of T cell effector functions.
INTRODUCTION
A key function of the immune system is to protect the organism
against transformed tumor cells. Cytotoxic killer T lymphocytes
(CTLs) are a crucial cell type in this context because they are ca-
pable of directly destroyingmalignant cells. This function of CTLs
depends critically on their capability to seek and recognize can-
cer and/or tumor-associated stromal cells that may be located
anywhere in the body (Mrass and Weninger, 2006). Thus, CTLs
must migrate from the blood stream into organs, find their way
through the extracellular matrix (ECM)-rich interstitial space,
and finally interact physically with target cells. Recognition of
peptide-MHC (pMHC) complexes by the T cell receptor (TCR)
then leads to the release of cytotoxic mediators and cytokines,
ultimately resulting in the death of their targets.ISeveral core activities of T lymphocytes, such as locomotion
through tissue stroma and cell-to-cell interactions, are associ-
ated with facultative polarity (Krummel and Macara, 2006; San-
chez-Madrid and del Pozo, 1999). Thus, the shape of a crawling
T cell is characterized by the formation of a flattened lamellipo-
dium at the leading edge and a small, handle-like protrusion at
the rear, the uropod. Chemotactic receptors are enriched at the
leading edge, where they may sense chemokine gradients within
tissues. In contrast, adhesion molecules, such as CD43, CD44,
and intercellular adhesion molecules (ICAMs), localize to the
uropod of motile T cells. After receiving a migratory stop signal
delivered by TCR-pMHC interaction, T lymphocytes change to
a more rounded morphology. Nevertheless, certain molecules,
such as the TCR, coordinately segregate to the T cell-target cell
interface to form the immunologic synapse (IS), whereas others,
such as CD43, move to the distal pole of the cell (Dustin, 2008;
Shaw, 2005). In naive T cells, the IS is thought to regulate cellular
activation and fate determination, whereas in effector CTLs it is
involved in the directed secretion of cytotoxic mediators (Chang
et al., 2007;StinchcombeandGriffiths, 2003). T lymphocyte loco-
motion and target cell interactions have been extensively studied
in cell culture and have revealed common and distinct regulatory
cues in the mediation of asymmetry during these activities. For
example, PSD-95/Discs-large/ZO-1 (PDZ)-containing proteins,
including the Par3, Crumbs, and Scribble complex, have
been implicated in coordinating surface-molecule distribution in
uropod-containing T lymphocytes and during IS formation
(Ludford-Menting et al., 2005). In contrast, MyH9, a nonmuscle
myosin heavy chain, is required for migration of T cells in vitro,
but dispensable for synapse formation in vitro (Jacobelli et al.,
2004). However, little is known about the molecular regulation
of facultative polarity and the consequences of its disruption in
T lymphocytes within a physiologic environment.
For gaining mechanistic insight into T lymphocyte function
in vivo, observation of cells by microscopic means is of great
advantage, because this allows direct characterization of mole-
cules involved in interactions with cellular and extracellular
components of their specific microenvironment. The need for
intravital imaging at high resolution has recently been met by
the availability of two-photon microscopy, which has enabled
the definition of the basic migratory patterns of lymphocytes in
lymphoid and inflammatory tissues (Bousso and Robey, 2004;mmunity 29, 971–985, December 19, 2008 ª2008 Elsevier Inc. 971
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2005; Ng et al., 2008). Thus, it has been shown that, in the ab-
sence of cognate antigen, naive and effector T cells in secondary
lymphoid and peripheral organs, respectively, are very actively
migrating and reveal a polarized shape. Upon antigen encounter,
both cell types undergo stable interactions with target cells, such
as dendritic cells or tumor cells. Although the molecular cues
regulating locomotion of T lymphocytes have been studied in
great detail in vitro, it is not yet known how these cells navigate
through their respective microenvironments in vivo.
We have previously shown that tumor-infiltrating T lympho-
cytes (TILs) were in close contact with ECM fibers (Mrass et al.,
2006), thereby suggesting the involvement of adhesion receptors
in this process. Among these molecules is CD44, a cell-surface
glycoprotein, which is subject to extensive alternative splicing
(reviewed in [Ponta et al., 2003; Pure and Cuff, 2001]). The extra-
cellular domain of CD44 can interact with ECM components,
including hyaluronic acid (HA), fibronectin, laminin, collagen,
and osteopontin. CD44 has been implicated in the interactions
of freshly activated T cells with blood vessel endothelium
(DeGrendele et al., 1997). However, it is unclear whether CD44
is involved in T cell migration outside the vascular system.
In addition to the roles of CD44 in T lymphocyte trafficking, the
intracellular domain of CD44 contains a number of bindingmotifs
for a variety of signalingmolecules implicated in cell-shape regu-
lation. For example, members of the ezrin, radixin, moesin (ERM)
family interact with CD44 (Turley et al., 2002). In an activated
(phosphorylated) state, these molecules act as crosslinkers of
the cortical actin filament and cell-surface receptors (Bretscher
et al., 2002).
On the basis of the above-described activities of CD44 and its
sequestered localization to the uropod of migrating T lympho-
cytes (Sanchez-Madrid and del Pozo, 1999), we speculated
that this molecule might be involved in the regulation of killer T
lymphocyte function in vivo. In order to test this hypothesis, we
exploited our recently developed two-photon imaging model of
intact tumors (Mrass et al., 2006). Our experiments showed
that CD44 regulates the navigation of TILs because of the polar-
ity-promoting function of its cytoplasmic domain. Together, our
study provided evidence that facultative polarity mediated by
CD44 is a key regulator of killer T cell migration and navigation,
and that even moderate disturbances in the ability to seek out
transformed cells have profound effects on the capacity to
ultimately reject tumors.
RESULTS
CD44 Is Dispensable for the Differentiation
and Trafficking of CTLs
In order to assess the role of CD44 in TIL function, we made use
of transgenic OT-I mice, whose TCR recognizes ovalbumin pep-
tide257-264, crossed to CD44-deficient (Cd44
/) animals. We
first determined whether CD44 deficiency changed the func-
tional properties of CD8+ T cells after antigen priming in vitro.
As expected, antigen-activated OT-I cells, but not OT-IxCd44/
cells, showed high and sustained expression of CD44 (Fig-
ure S1A, available online). Other phenotypic characteristics of
effector CTLs, such as the expression of L-selectin, CD69, and
CD25, the production of cytokines, and the expression of perforin972 Immunity 29, 971–985, December 19, 2008 ª2008 Elsevier Inc.and granzyme B, as well as cell proliferation, were not affected by
CD44 deficiency (Figures S1B–S1E and data not shown). Also,
OT-I and OT-IxCd44/ CTLs induced specific lysis of E.G7-
OVA target cells in vitro with similar efficiency (Figure S1F). In ad-
dition, CD44 was not required for motility of naive T cells in intact
lymph nodes or on in vitro substrata (Figure S2).
Previous studies have shown that T cells transiently upregu-
late HA-binding activity after stimulation (DeGrendele et al.,
1997; Lesley et al., 1994). Using flow cytometry, we confirmed
that cognate peptide activation induced HA-binding activity of
OT-I but not OT-IxCd44/ cells (Figure S3A). However, HA
binding was lost in fully differentiated CTLs at day 8 of culture
(Figure S3A). Similarly, tumor- and spleen-infiltrating CTLs iso-
lated ex vivo did not reveal HA-binding capability (Figure S3B).
As a positive control, CTLs were preincubated with mAb
IRAWB14, which induces HA-binding capacity of CD44 (Lesley
et al., 1993). At all time points, this treatment led to HA binding
of OT-I, but not OT-IxCd44/ CTLs (Figures S3A and S3B). To
further exclude the possibility that HA present in culture media
masked binding of exogenously added HA in terminally differen-
tiated CTLs, we incubated the cells with biotinylated HA-binding
protein (HABP). AKR cells transfected with full-length CD44
served as a positive control (Figures S4A and S4B). Freshly
stimulated, but not fully differentiated, OT-I cells bound HABP
in a CD44-dependent manner (Figures S4C–S4E). This sug-
gested that CD44 is in an inactive conformation on the
surface of fully differentiated CTLs. Consistently, adoptively
transferred OT-I and OT-IxCd44/ CTLs from day 8 cultures
homed to a similar extent into spleen and tumors (Figures
S5A–S5C).
CD44 Promotes Effective Navigation of TILs through
the Intact Tumor Microenvironment
The fact that CD44 appeared to be dispensable for effector CTL
generation in vitro as well as their accumulation in tumors
allowed us to further dissect its function in killer T cell behavior
in vivo. We employed our recently developed tumor-imaging
model, which enables tracking of fluorescently tagged TILs in
intact tumors (Mrass et al., 2006). Whenwe compared themigra-
tory activity of adoptively transferredOT-I or OT-IxCd44/CTLs
that infiltrated EL4 tumors that lack expression of cognate OVA
protein, we noted a migratory defect of CD44-deficient cells,
as evidenced by a reduction of their mean migratory velocity
(Vmean: OT-I, 7.5 mmmin
1; OT-IxCd44/, 4.9 mmmin1; Figures
1A–1C, Movie S1).
To obtain a more qualitative understanding of the motility de-
fect in the absence of CD44, we plotted the migration tracks of
individual cells corresponding to their Vmeans and confinement
ratios (defined as the total length of a track divided by the dis-
tance between the starting and the end points of a track). Subdi-
vision of this migration plot yielded four quadrants with distinct
migratory properties (Figure 1D). Quadrant 1 contains cells
with low Vmean and confinement ratio (‘‘lowmotility’’ cells). Quad-
rant 2 contains cells with low Vmean and high confinement ratio,
corresponding to cells that actively translocate only during
certain periods during the observation while also showing
substantial periods of immobility (‘‘nonsustained motility’’). In
quadrant 3, cells exhibit high Vmean and high confinement ratios,
which is representative of cells with robust migration with only
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show, for most of the observation period, active directional mi-
gration. However, at some point, they change direction followed
by directional migration toward the site of origin, as reflected by
a high velocity and low confinement ratio. CD44-deficient
CTLs contained an enhanced number of cells in quadrants 1
and 2, but reduced numbers in quadrant 3 and to a lesser
degree quadrant 4 (Figure 1E). These results show that CD44
is required for robust migration, which translates into a larger
tissue volume that is screened by wild-type as compared to
Cd44/ CTLs.
Wehavepreviously found that TILsmigrate randomlywithin tu-
mors (Mrass et al., 2006). To determine whether CD44 deficiency
changed this behavior, we analyzed square root of time versus
displacement plots (Cahalan et al., 2002) of cells in quadrant 3
and found that these exhibited random migratory directionality
(Figure 1F). This indicates that, regardless of their CD44 status,
CTLs, at the population level, do not appear to move along
Figure 1. CD44 Regulates the Navigation of Killer T Cells through the Tumor Microenvironment
(A–F) C57BL/6 mice were injected subcutaneously with EL4 cells (106) not expressing cognate antigen for OT-I T cells. After the tumors became palpable, CTLs
(23 107) at day 8 of stimulation generated from OT-IxDPEGFP or OT-IxCd44/xDPEGFP mice were adoptively transferred through the tail vein. Three days later,
the tumors (n = 14) were explanted and subjected to two-photon microscopy. T cells were tracked and analyzed. (A and B) Representative tracks of migrating
T cells (804500) are shown. (C) The distribution of the mean velocity of individual tracks is plotted. Arrows indicate the median velocity. (D) Individual tracks of
migrating cells were plotted according to their confinement ratio and mean velocity. Quadrants were set to distinguish four populations of cells. Symbols rep-
resent tracks of individual cells. (E) The distribution of the individual tracks within the four quadrants shown in (D) is depicted. (F) A square root of time versus
displacement plot was calculated from the tracks in quadrant 3.
(G–I) As in (C)–(E) except thatmicewere injectedwith E.G7-OVA tumors (n = 3) instead of EL4 tumor cells and that two-photon imagingwas carried out 4 days after
adoptive transfer.
Immunity 29, 971–985, December 19, 2008 ª2008 Elsevier Inc. 973
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microenvironment.
We next investigated the influence of cognate antigen on the
migration of OT-I and OT-IxCd44/ TILs. We have previously
shown that recognition of cognate antigen within target tissue
interferes transiently withmigration, resulting from physical inter-
actions with antigen-bearing tumor cells. However, to sustain
motility for prolonged periods after adoptive transfer, exposure
of T cells to cognate antigen within the tumor tissue is necessary
Figure 2. Direct Regulation of TIL Motility
by CD44
(A–D) E.G7-OVA tumor-bearing mice (as in Fig-
ure 1) were coinjected intravenously with 1.5 3
107 ECFP-OT-I and EYFP-OT-IxCd44/ CTLs.
Tumors (n = 5) were explanted on day 4 after
adoptive transfer. Two-photon imaging of ECFP+
and YFP+ cells and cell-tracking analysis was
carried as in Figure 1.
(E–H) OT-IxCd44/ CTLs transduced with ECFP
alone or CD44-IRES-GFP (1.5 3 107 cells each)
were adoptively transferred into EL4 tumor-bear-
ing mice. Tumors (n = 2) were explanted on day
3 after adoptive transfer. Two-photon imaging of
ECFP+ and GFP+ cells and cell-tracking analysis
were carried out as in Figure 1.
(Mrass et al., 2006). Given that TCR sig-
naling has a promigratory effect, it was
conceivable that signaling via the TCR
might overcome the migratory defect of
Cd44/ T cells. However, analysis of
the motility of CTLs in E.G7-OVA
tumors on day 4 after adoptive transfer
revealed a similar migratory defect of
OT-IxCd44/ cells to that found in EL4
tumors (Figures 1G–1I), demonstrating
that the migratory defect could not be
rescued by TCR signaling.
Because it could be argued that CD44
wild-type and Cd44/ cells localize to
different regions within tumors, and
that this resulted in their migratory differ-
ences, we performed cotransfer experi-
ments with differentially tagged cells
expressing enhanced yellow fluorescent
protein (EYFP) or enhanced cyan fluores-
cent protein (ECFP). This allowed the
simultaneous tracking of OT-I and
OT-IxCd44/ cells in identical tumor
subregions (Figure 2A, Movie S2). Con-
sistently, we found that under these
conditions Cd44/ cells showed signifi-
cantly reduced Vmeans and migratory
characteristics similar to what we ob-
served after single transfer of individual
cell populations (Figures 2B–2D), indicat-
ing that the reduced motility of Cd44/
cells is not due to accumulation in differ-
ent areas of the tumor.
To demonstrate that themigratory defect ofCd44/ cells was
indeed due to the absence of CD44 and not to other functional
differences of Cd44/ cells, we reintroduced full-length CD44
into Cd44/ T cells prior to adoptive transfer. In comparison
to control-transduced CTLs, CD44-reconstituted cells showed
enhanced motility after homing into identical regions in EL4
tumors (Figures 2E–2H, Movie S3). Collectively, we show that
CD44 is a direct regulator of the motility of killer T lymphocytes
within target tissues.
974 Immunity 29, 971–985, December 19, 2008 ª2008 Elsevier Inc.
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To dissect themolecular basis of the promigratory effect of CD44
in effector CTLs, we further analyzed the migratory characteris-
Figure 3. CD44 Promotes Polarity of Effec-
tor CTLs In Vitro and In Vivo
(A–C) CTLs generated from OT-I or OT-IxCd44/
mice at day 8of culturewere placed on top of a col-
lagen gel. With phase-contrast microscopy, time-
lapse sequences of the migratory behavior of the
cells were generated. Frameswere captured every
30 s for a period of 10.5 min. This was followed by
tracking and data analysis as in Figure 1. Note that
because of the faster migration velocities of T cells
in vitro, gates in (B) were set differently for the cell-
culture experiments as compared to in vivo (n = 4
independent experiments).
(D) T cell adhesion assay on 96-well plates un-
coated or coated with collagen or fibronectin.
Shown is the mean percentage of the adhering
cells (± the standard error of the mean [SEM];
n = 32 wells for each condition in four independent
experiments).
(E–G) CTLs cultured on plastic dishes were
imaged with phase-contrast microscopy. Cells
were categorized and quantified according to their
cell shape. Bars represent mean percentages
(± SEM; n = 3 independent experiments).
(H–J) Phase-contrast microscopy was used to
generate time-lapse sequences of CTLs cultured
on plastic dishes. The number of switches be-
tween round and extended shape was quantified
(OT-I: n = 81 cells; OT-IxCd44/: n = 103 cells).
Indicated are the means (± SEM) of the percent-
ages of switch frequencies within individual time
lapse-sequences ([J], n = 15 image sequences
from three independent experiments). Signifi-
cance was tested with two-way ANOVA.
(K) The experiment was carried out as in Figure 1.
Snapshots of time-lapse videos generated in Fig-
ure 1were taken, and the percentage of GFP+ cells
containing uropods was determined. Each symbol
represents the value obtained in an individual
region (four independent experiments. The lines
indicate means and SEM).
tics of wild-type andCd44/ T cells in an
in vitro system. CTLs were placed either
on top of a collagen gel (Figures 3A–3C,
Movie S4) or on immobilized fibronectin
(not shown). Wild-type cells migrated ef-
fectively onboth substrateswith amedian
Vmean of 11 and 9.9 mm min
1, respec-
tively. In contrast, Cd44/ lymphocytes
showed significantly reduced Vmeans
(collagen: 9 mm min1, p < 0.0001; fibro-
nectin: 8.5 mm min1, p < 0.0001). We
also found an increased proportion of
OT-IxCd44/ cells within quadrants 1
and 2 and decreased numbers in quad-
rant 3 when Vmeans were plotted against
the confinement ratio (Figures 3B and
3C). In order to test whether themigratory
defect of Cd44/ cells was due to altered adhesion, we used
static adhesion assays. CD44 deficiency did not affect binding
to uncoated dishes or fibronectin (Figure 3D). Immobilized type
Immunity 29, 971–985, December 19, 2008 ª2008 Elsevier Inc. 975
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-deficient CTLs, but rather seemed to block residual binding to
plastic (Figure 3D). Together, although not as pronounced as
in vivo, Cd44/ cells were impaired in their migration in vitro,
and this was independent of adhesion to the substrate.
An alternative explanation for the effects of CD44 could be that
it regulates cellular polarity. In fact, CD44 enhances anterior-
posterior asymmetry in neutrophils in response to chemokines
in vitro (Alstergren et al., 2004). To address this possibility, we
performed cell-shape analysis of CTLs. We classified CTLs on
the basis of three cellular shapes: round, extendedwith a uropod,
and extended without a uropod (Figure 3E). Comparison of the
frequency of round versus extended shapes revealed similar
values in both groups, suggesting that Cd44/ cells retain
their capacity to break radial symmetry (Figure 3F). However,
Cd44/ cells showed significantly reduced efficiency to form
uropods (Figure 3G), indicating that CD44 may promote migra-
tion by supporting cellular polarity.
On the basis of the finding that Cd44/ cells exhibited dimin-
ished uropod formation, but that neverthelessmost of these cells
were activelymigrating (at reduced speed and displacement), we
speculated that the lack of CD44 might impair sustenance of a
polarized shape. To test this possibility, we developed a shape-
changeassay tomeasure the robustnessof a sustainedpolarized
phenotype of CTLs. Thus, we counted the frequency of switches
between a nonpolarized (round) and polarized (extended) shape
on cells cultured in plastic dishes. Round wild-type cells that
developed an extended shape usually retained their shape
throughout the observation period, corresponding to a switch
rate of 1 (Figures 3H–3J,Movie S5A). In contrast, round knockout
cells that extended their shape frequently switched back to a
round shape, a cycle that was often repeated multiple times.
Thus, there was a significant increase in Cd44/ cells with
switch rates equal to or greater than 2 (Figure 3J, Movie S5B).
In order to confirm that a similar phenomenon was happening
in vivo, we determined the number of wild-type and Cd44/
OT-I T cells exhibiting uropods within EL4 tumors. Consistent
with the in vitro results, we observed a significant decrease in
uropod-containing cells within the Cd44/ population (Fig-
ure 3K). Together, these data indicate that the lack of CD44 leads
to an impaired capacity of CTLs to sustain mature polarization in
the front-rear axis.
The Intracellular Domain Regulates Membrane
Localization and Promigratory Effects of CD44
The results described so far suggested that the promigratory
function of CD44 is due to a polarity-sustaining activity that
occurs in the absence of ligand (HA) binding. To test whether
this deficiency could be rescued by CD44, we transduced
Cd44/ CTLs with the full-length molecule. CD44 expression
levels in transduced cells were similar to that of wild-type OT-I
cells transduced with green fluorescent protein (GFP)-encoding
control retrovirus (Figure S6). When placed on top of a collagen
gel, CD44-transduced cells showed enhanced motility when
compared with nontransduced (GFP) Cd44/ cells or cells
transduced with a vector that confers GFP but not CD44 expres-
sion (Figures 4A–4C).
To determine the functional domains important for promoting
migration, we transduced Cd44/ CTLs with mutant CD44,976 Immunity 29, 971–985, December 19, 2008 ª2008 Elsevier Inc.CD44DECD, containing a truncated extracellular domain of only
19 amino acids, which lacks the HA-binding link domain and is
therefore principally deficient in its receptor function (Peach
et al., 1993) (Figure 4D). A second group of cells was transduced
with CD44DICD containing a truncated cytoplasmic domain of
only seven cytoplasmic amino acids, thereby lacking any func-
tional adaptor domains (Figure 4D). A third group was trans-
duced with full-length CD44 as a control (Figure 4D). Expression
of CD44DECD had a promigratory effect similar to that of wild-
type CD44 (p > 0.05; Figure 4E). In contrast, cells expressing
CD44DICD showed reduced motility versus full-length CD44-
and CD44DECD-transduced cells (p < 0.001), but equal motility
as nontransduced cells or cells transduced with GFP-only
vectors (p > 0.05, Figure 4E).
To assess whether these effects might be due to changes in
the subcellular organization of CD44 molecules, we generated
retroviruses conferring expression of GFP-taggedCD44 proteins
(Figure 4D). CD44-GFP proteins showed similar surface expres-
sion levels and promigratory function as the nontagged corre-
lates (Figure 4F and Figure S7). As described previously,
full-length CD44 was enriched at the uropod of polarized T cells
(Sanchez-Madrid and del Pozo, 1999) (Figure 4G, red arrow-
heads). Consistent with the migration analysis, the extracellular
domain (ECD) was dispensable to achieve this positioning (Fig-
ure 4G). In contrast, deficiency of the intracellular domain (ICD)
led to a redistribution of CD44 with punctate, cytoplasmic stain-
ing pattern in addition to some surface staining (Figure 4G).
Together, these data provide evidence that the intracellular, but
not the extracellular, domain is important for the promigratory
activity of CD44 in effector CTL.
The Promigratory Effect of the ICD Is Mediated
by pERM Recruitment to the Plasma Membrane
The ICD of CD44 contains an ERM binding domain. Phosphory-
latedERM (pERM) haspreviouslybeenshown topromotecell po-
larity andmigration by its capacity to link the actin cytoskeleton to
themembrane, and to assemble amembrane-targetedmultimo-
lecular signaling complex (Bretscher et al., 2002). To address
whether ERM members were involved in the effects of CD44 on
mediating CTLs polarity and migration, we determined the sub-
cellular localization of pERM in wild-type and Cd44/OT-I cells
by immunofluorescence microscopy. Sixty-five percent of wild-
type cells revealed accumulation of surface-localized pERM (Fig-
ure 5A). In polarized cells, pERM showed a predilection to the
uropod, correlating with the expression pattern of CD44 (Fig-
ure5A, redarrow). In contrast,Cd44/cells showedasignificant
reduction in the capacity to induce localized accumulation of
pERM (Figure 5A).
To further assess whether pERM interaction was responsible
for CD44 recruitment to the uropod, we generated a deletionmu-
tant, CD44DERM-GFP, that specifically lacked the ERM-binding
domain (Yonemura et al., 1998). Flow cytometry revealed that
surface expression of CD44DERM-GFP was similar to that of
full-length CD44-GFP (Figure 5B). Using fluorescence micros-
copy, we determined that CD44DERM-GFP was strongly en-
riched at the membrane. However, in contrast to the asymmetric
distribution of CD44-GFP in polarized cells, CD44DERM-GFP
was distributed evenly on the membrane of OT-I cells (compare
Figures 5C and 5D). Thus, the ERM-binding domain appears
Immunity
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but plays a function in enriching CD44 to particular subregions.
We then generated time-lapse movies of in vitro-cultured CTLs
expressing CD44-GFP or CD44DERM-GFP. Strikingly, CD44-
GFP accumulated at discrete membrane locations preceding
the formation of a uropod (Movies S6A and S6C). This was fol-
lowed by forward translocation of the cell body (Movies S6A
and S6C). In contrast, CD44DERM-GFP failed to accumulate
Figure 4. The Intracellular Domain of CD44 Promotes T Lymphocyte Migration In Vitro
(A–C) CTLs generated from OT-IxCd44/ mice were transduced with a retrovirus conferring expression of GFP and CD44 (MigR1-CD44) or GFP only (MigR1).
Time-lapse sequences of CTLs migrating on a collagen gel were captured simultaneously with phase-contrast and fluorescence microscopy to track GFP+
(transduced) and GFP (nontransduced) CTLs. Data analysis was carried out as in Figure 1 (n = 2 independent experiments).
(D) Schematic representation of the different forms of CD44 used in the experiments.
(E) CTLs generated fromOT-IxCd44/mice were transduced with retrovirus conferring coexpression of GFP and the CD44 variants symbolized in (D). Migratory
velocities were determined [MigR1-CD44 (GFP+): n = 100 tracks; MigR1-CD44DICD (GFP+): n = 106 tracks; MigR1-CD44DECD (GFP+): n = 119 tracks;
MigR1-CD44 (GFP-): n = 62 tracks; MigR1-CD44DICD (GFP): n = 62 tracks; MigR1-CD44DECD (GFP): n = 60 tracks; data generated from two independent
experiments].
(F and G) CTLs generated from OT-IxCd44/ mice were transduced with FGM-retrovirus conferring expression of the CD44-GFP variants symbolized in (D). (F)
CD44 expression on GFP+ cells was analyzed by flow cytometry. (G) Representative GFP+ T cells in the individual groups were captured with fluorescence
microscopy.
Immunity 29, 971–985, December 19, 2008 ª2008 Elsevier Inc. 977
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shape changes of the cells with little to no forward propulsion
(Movies S6B and S6D). Consequently, CD44DERM-GFP-ex-
pressing cells migrated significantly slower than those express-
ing full-length CD44 or CD44DECD-GFP (p < 0.001), but similarly
to cells expressing CD44DICD-GFP or GFP alone (p > 0.05)
(Figures 5E–5G). These data suggest that pERM recruitment to
the ICD of CD44 stabilizes cell polarity, which in turn supports
migration.
CD44 Is Critical for Target Cell Screening
Efficiency of TILs
Having defined the migratory defect of Cd44/ effector CTLs
both in vitro and in vivo, it was important to determine the role
of CD44 in interactions with target cells, one of the hallmark ac-
tivities of cytotoxic T cells. One possibility was that the reduced
interstitial migration ofCd44/ T cells leads to a reduced capac-
ity to screen the tissue for the presence of target cells. To test this
hypothesis, we measured the frequency of tumor cell contacts
Figure 5. Recruitment of ERM Is Required for the Promigratory Effect of CD44 in Killer T Lymphocytes
(A) CTLs were permeabilized and stained with mAb against pERM and analyzed by immunofluorescence microscopy. The percentage of cells with polarized
localization of pERM was determined. Statistical significance was calculated with the Chi-Square test.
(B–G) CTLs generated from OT-IxCd44/ mice were transduced with a retrovirus conferring expression of the indicated CD44-GFP constructs. (B) CD44
expression on GFP+ cells was analyzed by flow cytometry. (C and D) Representative snapshots of in vitro-cultured CTLs transduced with CD44-GFP
or CD44DERM-GFP are shown. (E–G) The motility of CTLs transduced with the indicated retroviral constructs on collagen gels was analyzed as in Figure 1
(n = 2 independent experiments).
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tions.We found that wild-type T cells detaching from a tumor cell
after a short-term interaction typically succeeded in reinitiating
interstitial migration, followed by subsequent interactions with
several additional tumor cells (4.1 ± 0.2 interactions during the
observation period of 30 min; Figures 6A and 6B). In contrast,
after terminating a short-term interaction, CD44-deficient cells
exhibited cell shape changes that failed to translate into effective
forward propulsion, leading to significantly reduced subsequent
tumor cell encounters (1.5 ± 0.2 interactions; p < 0.0001; Figures
6A and 6B). The reduced capacity to screen for target cells was
also reflected by prolonged time periods that noninteracting
Cd44/ cells required for establishing contacts with tumor cells
(Figure 6C). This defect led to a pronounced increase in Cd44/
TILs that failed to bind to any tumor cells during a 30 min obser-
vation period (Figure 6D). These results provide direct evidence
that the target cell screening efficiency is decreased in Cd44/
T cells.
CD44 Is Dispensable for the Quality of T Lymphocyte
Interactions with Target Cells In Vivo
We next determined the quality of cellular interactions once
they were established by TILs. Previous evidence supports the
importance of polarization in cellular interactions of CTLs. For
example, interference with the polarity network in CTLs has
profound effects not only on migration, but also on IS formation
following TCR signals in CTLs in vitro (Ludford-Menting et al.,
2005), attesting to similar regulatory cues of these processes.
We adoptively transferred graded numbers (2 3 106, 5 3 106,
2 3 107) of OT-I T cells into mice harboring E.G7-OVA-ECFP tu-
mors (Mrass et al., 2006), and analyzed cellular interactions at
different time points. Similar to what we found with OT-I CTLs
(Mrass et al., 2006),Cd44/OT-I cells underwent both transient
and long-term interactions within E.G7-OVA tumors (Figures 6E
and 6F, Movie S7). Strikingly, the duration of Cd44/ cell inter-
actions was indistinguishable from their wild-type counterparts
(Figure 6F, Movie S7), indicating that CD44 is not involved in
physical contacts of TILs. These results further suggest that
facultative polarity in migrating and interacting T cells are molec-
ularly distinct processes.
Cd44/ CTLs Are Impaired in Their Tumor-Rejecting
Activities
Together, our results show that Cd44/ lymphocytes exhibit
a specific defect in interstitial migration and screening for target
cells, but that they are still capable of recognizing target cells.
This may not be so relevant during the early phase of tumor re-
jection, when the tumor bed is densely packed with tumor cells
(Figure S8A), and CTLs do not have to migrate over prolonged
distances in order to find a target. However, at later stages
(beginning on day 4 after adoptive transfer) tumor cells become
less dense because of apoptosis (Figures S8B and S8C). At this
stage, TIL migration may be essential to detect and destroy tar-
get cells. In addition, at high T cell frequency within tumors, the
consequence of a migratory defect may not be as apparent as
when T cells are present at low densities, because the likelihood
of tumor cell encounters would be higher in the former scenario.
In order to test this prediction, we measured the growth of
tumors in mice bearing E.G7-OVA tumors that received gradeddoses of wild-type or Cd44/ antigen-specific OT-I CTLs. Irre-
spective of their CD44 status, CTLs initially induced regression of
growing tumors. This effect was more pronounced when higher
numbers of CTLs were transferred (Figure 7A). Strikingly, begin-
ning 4 days after CTL transfer, the efficacy of CD44-deficient
CTLs to induce tumor shrinkage was reduced (Figures 7A and
7B). Particularly at lower T cell numbers, this led to an acceler-
ated reoccurrence of tumors in the Cd44/ group (Figures 7A
and 7B). The percentage of large tumors (>100 mm3) was signif-
icantly higher in mice receiving knockout CTLs (Figures 7C and
7D). Together, this resulted in increased mortality of the mice
in the Cd44/ CTL group (Figure 7E).
In order to exclude the possibility that the failure of Cd44/
T lymphocytes to permanently reject tumors was due to a differ-
ence in survival as compared to wild-type cells, we determined
the number of cells accumulating in EL4 tumors and the spleen
in a time course (Figure 7F and data not shown). These experi-
ments showed that Cd44/ T cells persisted to the same extent
as their wild-type counterparts for at least 9 days after adoptive
transfer. In addition, we counted wild-type OT-I cells in three
individual E.G7-OVA tumors that were not rejected. We found
that there were identical numbers of wild-type and Cd44/
CTLs in these tumors (data not shown).
In summary, these results indicate that CD44 is an important
determinant of the tumor-rejecting capability of TILs, most likely
relating to the promigratory effects of this molecule.
DISCUSSION
Cellular polarity is a hallmark of two main activities of killer T
lymphocytes, locomotion through tissue stroma and physical
interactionswith target cells. The results in thepresent paper pro-
vide insight into the molecular basis of polarity formation in CTLs
directly within the intact tumor microenvironment. We found that
interference with sustained polarity resulting from CD44 defi-
ciency decreases the capability of these cells to migrate through
the effector site, but does not impact the stability of interactions
with target cells. Thus, our study demonstrates that facultative
polarity established during migration and cellular interactions
are molecularly distinct processes. In addition, we show that
the fine tuning of killer T cell navigation through the interstitial
space is essential for efficient screening for tumor cells, which
in turn leads to efficient tumor cell surveillance.
The capability to rapidly migrate to any site in the body is a
defining feature of T cells, which ensures that they detect and
destroy target cells. Several distinct migratory checkpoints reg-
ulate the appropriate targeting of T cells into peripheral tissues.
In the initial step, T lymphocytes enter organs from the blood
stream, which is achieved by a cascade of specific molecular
interactions with the vascular endothelium culminating in firm
lymphocyte adhesion (reviewed in [Springer, 1994]). In the sec-
ond step, adherent T cells transmigrate through the vascular
wall, eventually reaching the interstitial space of target organs.
Finally, after entering the tissue stroma, T cells crawl through
the extracellular matrix, thus presumably facilitating the screen-
ing for cells presenting cognate antigen on their surface. Themo-
lecular and biophysical cues underlying the first two steps have
been studied in great detail both in vitro and in vivo. Our data
clearly demonstrate that interstitial effector T cell migration isImmunity 29, 971–985, December 19, 2008 ª2008 Elsevier Inc. 979
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Intratumoral T Cell MigrationFigure 6. CD44 Modulates Target Cell Screening Efficacy but Is Not Involved in Physical Interactions between Killer T Lymphocytes
and Tumor Cells
C57BL/6mice were injected subcutaneously into the flank with E.G7-OVA-ECFP tumor cells (106). After 9 days, 23 106, 53 106, or 23 107 CTLs generated from
OT-IxDPEGFP or OT-IxCd44/xDPEGFP splenocytes were adoptively transferred. Two, three, and four days later, the tumors were explanted and subjected to
two-photonmicroscopy. (Day 2:WT, n = 3 tumors;Cd44/, n = 3 tumors. Day 3:WT, n = 4 tumors;Cd44/, n = 5 tumors. Day 4:WT, n = 5 tumors;Cd44/, n = 3
tumors for each T cell group.)
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the effectiveness of the immune response.
Our study shows that CD44 regulates T cell locomotion
through the tumor stroma, but not trafficking of CTLs to tumors.
Although it has been known for a long time that CD44 expression
is strongly induced in T cells by TCR signals, its precise role in
T cell function has remained incompletely understood. Previous
studies have found that CD44 is involved in homing of T lympo-
cytes to sites of inflammation, probably via mediating interaction
of blood-borne T cellswith the endothelial wall (DeGrendele et al.,
1997). Nevertheless, in our experiments, CTLs homed effectively
into subcutaneous tumors, irrespective of their CD44 status. In
their original study, DeGrendele et al. (1997) used short-term
in vivo-activated CD4+ T cells with high HA-binding activity for
their homing experiments. Consistent with previous data assess-
ing HA binding to T cells during immune responses (Lesley et al.,
1994), we found that terminally differentiated CTLs showed high
CD44 expression but no HA-binding capacity. Therefore, it
appears that CD44 may have an early, transient function in the
homing process of T cells into peripheral sites, whereas at later
time points it is dispensable for T cell trafficking.
To better understand T cell activities in the extravascular
space, we made use of time-lapse two-photon microscopy.
Recently, this technology has been used to unravel the cellular
dynamics and anatomical context of T cell migration in intact
tissues. Thus, it has been shown that, in the absence of cognate
antigen, naive T cells in peripheral lymph nodes migrate very
actively and in random directions, a process partially dependent
on chemokine signals (Miller et al., 2002; Worbs et al., 2007). Al-
though naive T cells appear to use the fibroblastic reticular cell
network as a migratory guidance cue (Bajenoff et al., 2006), the
molecules mediating these interactions are unknown. In contrast
to lymph node, tumors do not contain an organized fibroblastic
reticular cell (FRC) network. Nevertheless, the ECMat these sites
is rich in HA and collagen fibers (Condeelis and Segall, 2003;
Knudson, 1996; Ricciardelli and Rodgers, 2006; Zalatnai, 2006),
and our previous observation that migrating TILs underwent inti-
mate interactions with ECM fibers (Mrass et al., 2006) suggested
that these structures may serve similar purposes for CTLs as the
FRC network does for naive T cells.
It has been proposed that leukocytes undergo only transient or
no firm adhesion with the substrate both in three-dimensional
(3D) models in vitro and in tissues in vivo. Thus, it has beensuggested that lymphocytes extend cell protrusions into tissue
pockets to generate mechanical traction (Schor et al., 1983).
This process has been dubbed ‘‘biophysical migration’’ andmay
explain why leukocytes migrate more than 100 fold faster than
epithelial or mesenchymal cells (Friedl et al., 2001). Recent evi-
dence has shown that leukocyte migration in 3D collagen gels
is completely independent of integrins, but rather relies on the
force generated by actin network expansion (Lammermann
et al., 2008). Our data extend this notion because they suggest
that the ECD of CD44 is dispensable for migration of activated
T cells in vitro, whereas the ICD is sufficient to restore normal mi-
gration in Cd44/ cells. This indicates that the effect of CD44 in
CTLs may be independent of ligand binding in situ, which is
further substantiated by the inactive, i.e., HA nonbinding, state
of the molecule on TILs isolated from tumors.
Although Cd44/ CTLs showed normal adhesive function
towardECMcomponents in vitro, theyweredeficient in formation
of amature polarized cell shape, evidenced by the reduced pres-
ence of uropods in migrating cells both in vitro and in vivo. In
contrast to molecules such as Scribble, CD44 does not appear
to be required for the initiation of polarity, i.e., symmetry breaking
(Ludford-Menting et al., 2005). Rather, it seems to function as
a polarity stabilizer, shown by shape-change assays of migrating
CTL. In contrast to the requirement of CD44 in the regulation of
polarity during migration, Cd44/ CTLs interacted with tumor
cells similarly to wild-type T lymphocytes. This is consistent
with the observation that, morphologically, interacting wild-type
(and Cd44/) TILs did not reveal clearly formed uropods, but
were usually of round shape. Therefore, we propose that the
main function of CD44 in T lymphocytes within the interstitial
space is the organization of cell shape during active migration.
At themolecular level, upon ligand binding, the cyoplasmic do-
main of CD44 has been shown to recruit a number of molecules,
includingERMfamilymembers, ankyrin, small RhoGTPases, and
tyrosine kinases, thereby transducing signals from the cell sur-
face to the cytoskeleton (Bretscher et al., 2002; Ponta et al.,
2003; Turley et al., 2002). Several of these pathways have been
proposed to mediate the promigratory effects of CD44. In vitro
experiments have indicated the involvement of ERM molecules
in the regulation of directional migration of fibroblasts and mela-
noma cells after exposure to chemokines (Legg et al., 2002).
However, despitemapping of the ERM-binding domain to a short
amino acid stretch at the intracellular domain of CD44, and the(A) Snapshots from time-lapse sequences from mice that received 23 106 CTLs are shown. CTLs (green) are indicated with green arrowheads. Individual tumor
cells are labeled with numbers to identify them throughout the observation period. The time is indicated in min:s in the upper-left corner of each panel. Tracks are
indicated by white lines.
(B) Tumor regions from mice that received 2 3 106 CTLs were analyzed for the frequency of cellular interactions. Only CTLs that could be tracked for 30 min,
engaged in at least one short-term interaction (<10 min) with a tumor cell, and did not show any long-term interactions were included. The number of tumor cells
that were targeted by these cells was counted. Bars represent means ± SEM. The data were generated from three independent experiments (WT: n = 10 CTLs;
Cd44/: n = 13).
(C) The areas analyzed in (B) were also analyzed for the time required for TILs to establish contacts with tumor cells. TILs that were not in contact with tumor cells
were tracked until they made contact with a tumor cell. The elapsed time period was measured and plotted. Line indicates the mean.
(D) The areas analyzed in (B) were used to determine the number of TILs that succeeded in establishing contacts with tumor cells. TILs were observed for a 30min
time period. Cells that achieved contacts with at least 1 tumor cell were designated ‘‘interacting’’ cells; cells that failed to achieve contacts with any tumor cells
were designated ‘‘noninteracting’’ cells. Shown is the number of interacting and noninteracting T cells.
(E) A representative long-term interaction between an OT-IxCd44/ T cell (green) and an E.G7-OVA-ECFP tumor cell (blue) is shown. The time is indicated in the
upper-left corner of each panel (min:s).
(F) The duration of interactions between E.G7-OVA-ECFP tumor cells and CD44-expressing or Cd44/ CTLs was measured (23 107: OT-I, n = 46 interactions;
OT-IxCd44/, n = 69 interactions. 53 106: OT-I, n = 41 interactions; OT-IxCd44/, n = 52 interactions. 23 106: OT-I, n = 47 interactions; OT-IxCd44/, n = 60
interactions).
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C57BL/6 mice were injected subcutaneously with E.G7-OVA cells (106). After 9–10 days, 2 3 107 (A) or 2 3 106 (B–E) CTLs generated from OT-IxDPEGFP or
OT-IxCd44/xDPEGFP mice were adoptively transferred into tumor-bearing mice. In (A), n = 58 tumors for each T cell group; in (B)–(E) n = 30 and 28 tumors
for OT-I and OT-IxCd44/ CTLs, respectively.
(A and B) The mean tumor volume (± SEM) was calculated for each group.
(C) The proportion of mice with tumors larger than 100mm3 after adoptive transfer is depicted. Chi-square test was used for each time point to determine whether
the proportions of rejected tumors in each group were different (**, p < 0.005; *, p < 0.05; $, p > 0.1).
(D) The mean volume (± SEM) of tumors with a size larger than 100 mm3 (day 10) was determined. Repeated-measures two-way ANOVA was carried out to
determine whether interaction occurs between the two curves (n = 6 and 11 tumors for wild-type and Cd44/ CTLs, respectively).
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with chemotaxis in a dominant-negative manner, the precise
function of the ERM-binding domain in the effects of CD44 on
T cell behavior has been unknown (Legg et al., 2002; Ponta
et al., 2003). Our results provide genetic evidence that recruit-
ment of pERM to the CD44 ICD is required for the promigratory
effect of CD44 in CTLs. CD44 promotes enrichment of pERM at
the membrane, and reciprocally, interaction with pERM is re-
quired for CD44 to become polarized at themembrane. It is likely
that after recruitment to the membrane, pERM crosslinks the
actin cytoskeleton, leading to the localized enrichment of the
CD44-pERM complex. Our data are consistent with a recent
study in a thymomacell line showing that a pERMsupports polar-
ity by the assembly of a molecular complex supporting ‘‘posteri-
ority’’ (Lee et al., 2004).
The fact thatCd44/CTLs exhibit a specific defect in intersti-
tial migration, whereas all other investigated properties, includ-
ing homing, cytotoxicity, and cytokine production, remain fully
functional, suggests that migration is indeed an integral part of
the function of CTLs. Nevertheless, it is worthwhile to note that
at very early time points, where the tumor tissue is still packed
with target cells (i.e., up to day 3 after adoptive transfer), the
effects of Cd44/ CTLs were comparable to wild-type cells.
Thus, initially, rejection of tumors was induced to a similar extent.
In contrast, beginning on day 4 after adoptive transfer, Cd44/
cells showed a substantial decrease in their antitumor effect.
Under these conditions, the density of target cells is reduced,
and a large fraction of the tumor volume comprises inflammatory
cells and dead tumor cells. We speculate that optimal interstitial
migration is required at the later phase of tumor rejection, which
is based on the sufficient detection of target cells within the tu-
mor bed. Hence, if CTL locomotion is disturbed at this time point,
residual tumor cells have the chance to escape immunosurveil-
lance resulting in early reoccurrence of overt cancer. Together,
these results indicate an early and late phase in tumor destruc-
tion, defined by the migratory properties of effector T cells and
regulated by CD44.
EXPERIMENTAL PROCEDURES
Mice
Mouse strains included DPEGFP mice, in which GFP is expressed by all T cells,
TCR-transgenic OT-I mice, and OT-IxDPEGFP mice (Mempel et al., 2006;
Mrass et al., 2006). Cd44/ mice, crossed to the C57BL/6 background for
more than 10 generations, were bred with OT-I or OT-IxDPEGFP strains.
C57BL/6 wild-type mice were obtained from Charles River Laboratories. All
experimental protocols including animals were approved by the Institutional
Animal Care and Use Committee of The Wistar Institute.
Cell Lines
The thymoma EL4 line and its OVA-expressing derivative (E.G7-OVA) were
purchased from the American Type Culture Collection. For some experiments,
ECFP-expressing EL4 and E.G7-OVA cell lines were used (Mrass et al., 2006).
AKR T lymphoma cells, which do not express CD44, and a stably transfected
CD44 variant (AKR-CD44) were employed as controls for hyaluronic acid
binding assays (Lesley et al., 1992).Reagents
Antibodies directed against the following antigens were used: CD8, CD44,
CD25, CD69, L-selectin, interferon-g, TNF-a, and IL-2 (BD Biosciences); per-
forin (clone eBioMAK-D; eBioscience); and granzyme B (Caltag/Invitrogen). A
phospho-ERM-specific antibody was purchased from Cell Signaling (#3141).
IRAWB14 is a mAb that induces hyaluronic acid binding activity of CD44
(Lesley et al., 1992). CD44-blocking antibody was generated from hybridoma
KM81 (American Type Culture Collection, TIB-241). Rooster-comb-derived
hyaluronic acid, bovine-plasma-derived fibronectin and rat-tail-derived type
I collagen were purchased from Sigma. Bovine-tendon-derived collagen was
kindly provided byM. Herlyn, TheWistar Institute. Hyaluronic acid was labeled
with fluorescein isothiocyanate (Cichy and Pure, 2004). Biotinylated hyaluronic
acid binding protein was purchased from Associates of Cape Cod. R-phyco-
erythrin (PE)-conjugated streptavidin was purchased from Dako. Collagenase
D and DNase I were purchased from Roche. Phorbol-myristate-acetate and
ionomycin were purchased from Sigma. SIINFEKL peptide was purchased
from Alpha Diagnostic International.
Cytotoxicity Assay
The cytotoxic activity of CTLs was determined with the CyToxiLux assay as
recommended by the manufacturer (OncoImmunin). In brief, tumor cells
(EL4 or E.G7-OVA) were fluorescently labeled with a red dye, followed by co-
incubation of CTLs and tumor cells in the presence of a fluorogenic caspase
substrate that shows enhanced green fluorescence after caspase-mediated
cleavage.
Flow Cytometry
Excised tumors were cut into small pieces and incubated in HBSS containing
10 mg ml1 collagenase D and 1 mg ml1 DNase I. The digested tissue was
transferred through a cell strainer to generate a single-cell suspension.
Spleens were passed through a cell strainer, followed by lysis in ACK lysing
buffer (Invitrogen). The resulting single-cell suspensions were stained in PBS
with 1% fetal bovine serum with the appropriate antibodies followed by
analysis with a FACSCalibur flow cytometer (Becton Dickinson). Data were
analyzed with FlowJo software (Tree Star).
Adoptive Transfer of CTLs into Tumor-Bearing Mice
C57BL/6 mice are injected subcutaneously with 106 EL4, E.G7-OVA, or E.G7-
OVA-ECFP tumor cells into both flanks. Eight to ten days after tumor cell
injection, CTLs (2 3 107 unless indicated otherwise) at day 8 of culture were
adoptively transferred by tail-vein injection.
Analysis of Tumor Growth
The experimental endpoint was defined when tumor volume exceeded 10% of
body weight of mice. For calculation of tumor volumes, the longest and short-
est diameter of tumors was measured. The volume was calculated according
to the following formula: (longest diameter) 3 (shortest diameter)2 3 p/6.
Fluorescence Microscopy
For analysis of GFP, cultured cells were directly analyzed in T75 culture dishes
at 37C and 5% CO2. Images and time-lapse videos were captured on an in-
verted microscope (Nikon TE300). For detection of pERM by immunofluores-
cence microscopy, cells were transferred into 6-well plates and incubated for
30 min at 37C and 5% CO2. The cells were fixed immediately after removal
from the incubator directly on the culture dish with trichloroacetic acid.
T Cell Shape-Change Assay
Cultured CTLs (day 8 after peptide stimulation) were resuspended in fresh
IL-2-supplementedmedia and added into uncoated 6-well plates. Phase-con-
trast microscopy was used to generate time-lapse sequences. Individual
frameswere captured for 1003000 every 30 s. An extendedmorphology that per-
sisted for at least two frames, followed by a round morphology that persisted(E) Survival curves of tumor-bearingmice thatwere treatedwithOT-IxDPEGFPorOT-IxCd44/xDPEGFPTcells (n=15 and14mice, respectively)were determined.
(F) C56BL/6 mice were injected subcutaneously with EL4 tumor cells (106). At the indicated time points, single-cell suspensions of the tumors were generated,
and the numbers of OT-I and OT-IxCd44/ TILs were determined by flow cytometry (day 3: n = 16 and 14 tumors, respectively; day 6: n = 20 tumors each; day 9:
n = 4 tumors each).
Immunity 29, 971–985, December 19, 2008 ª2008 Elsevier Inc. 983
Immunity
Intratumoral T Cell Migrationfor at least two frames, and vice versa, was defined as one switch between
polarized and nonpolarized states. Only cells that showed a roundmorphology
for at least two frames were included in this analysis.
Two-Photon Microscopy of Tumors and Imaging Analysis
Tumor tissue preparation was carried out as described previously (Mrass et al.,
2006). In brief, tumors were explanted and placed in an imaging chamber.
Superfusion with prewarmed and oxygenated medium was carried out
throughout the experiment to maintain tissue viability. Two-photon micros-
copy and imaging analysis was carried out on a Prairie Technology Ultima Sys-
tem equipped with a 403 (NA 0.8) water-immersion objective in combination
with a diode-pumped, widebandmode-locked Ti:Sapphire femtosecond laser
(Coherent Chameleon). Tissues were exposed to laser light at a wavelength of
900 nm. Appropriate filter sets were used to specifically detect light emitted as
a result of second harmonic generation or by the excited fluorophores. 3D im-
age stacks were transformed into movies with Volocity software (Improvision).
Mean migration velocities, cellular displacement, and confinement ratios (total
length of track divided by distance between starting and end point), as well as
turning angles and instantaneous velocity, were calculated as described
(Mrass et al., 2006).
In Vitro T Cell Migration Assay
A collagen suspension (1mgml1) was diluted 1:5 in PBS and 0.2%bovine se-
rum albumin. One hundred microliters of this solution was placed in 96-well
plates andsolidified for 2 to 16hr at room temperature. Alternatively, fibronectin
(10 mg ml1) was used to coat plates. OT-I effector T cells (105) in prewarmed
media (100 ml) supplemented with IL-2 (20 ng ml1) were added. After the cells
settled, they were imaged with fluorescence and phase-contrast microscopy
(Nikon TE300 microscope) to capture and distinguish cells with and without
fluorescent tag. Time-lapse sequences of 1003000 duration with one frame cap-
tured every 30 s were generated. T cell motility parameters were analyzed with
Volocity software and calculated as described for intact tissues.
T Cell Adhesion Assay
The adhesion assay was carried out as described recently (Fukunaga-Kalabis
et al., 2006). In brief, 96-well plates were coated with fibronectin (10 mgml1) or
collagen (30 mg ml1). Cells were added as described for the in vitro migration
assay. After settling of the cells, the wells were rinsed gently with PBS, and the
supernatant was removed by vacuum suction. The remaining cells were incu-
bated in fixation solution (10% ethanol, 0.2% crystal violet). After washing, the
dye retained by adherent cellswas releasedby incubation in a lysis buffer (0.1M
NaH2PO4, pH 4.5). The turbidity of the supernatant was determinedwith a plate
reader set to 570 nm (Model 550, BioRad). The adhesion percentage was
calculated by interpolation, fitting themeasured value to a linear functionwhere
0% corresponds to the value that obtained for empty wells and 100% corre-
sponds the value obtained in wells where the washing step was omitted.
Statistical Methods
Unless indicated otherwise, Mann Whitney test was used for comparisons of
two groups. Kruskal-Wallis followed by Bonferroni test was used for compari-
sonsofmore than twogroups. Thechi-square testwasused for thecomparison
of categorical data. KS normality test and D’Agostino & Pearson omnibus nor-
mality test were employed when using assays that require normal distribution.
A difference was considered significant if p < 0.05. The error bars in all charts
represent standard errors of the mean.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, nine fig-
ures, and seven movies and can be found with this article online at http://
www.immunity.com/supplemental/S1074-7613(08)00513-X.
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